Quick search for therapies
1 result (filtered)
Page 1 / 1
1
Kleeberg, U.R.; Suciu, S.; Bröcker, E.B.; Ruiter, D.J.; Chartier, C.; Liénard, D.; Marsden, J.; Schadendorf, D.; Eggermont, A.M.M.
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
RIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness > 3 mm) or regional lymph node metastasis
Eur J Cancer, 2004, 40, 390-402
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
RIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness > 3 mm) or regional lymph node metastasis
Eur J Cancer, 2004, 40, 390-402
Blood/Lymphatic system, Clinical research, Complementary and alternative medicine, Cancer, Lymphatic system, Malignant melanoma, Mistletoe therapy, Phytomedicine, Randomized trial, Viscum, Viscum album, Iscador